George Soros's position in Apellis Pharmaceuticals is currently worth $43.3M. That's 0.50% of their equity portfolio (35th largest holding). The first Apellis Pharmaceuticals trade was made in Q1 2024. Since then George Soros bought shares one more times and sold shares on one occasions. The stake costed the investor $22.8M, netting the investor a gain of 90% so far.